DAFNA Capital Management as of Sept. 30, 2015
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 88 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 10.6 | $11M | 488k | 21.91 | |
| Abbvie (ABBV) | 6.3 | $6.3M | 117k | 54.41 | |
| NxStage Medical | 5.7 | $5.8M | 367k | 15.77 | |
| Zs Pharma | 4.3 | $4.3M | 66k | 65.66 | |
| Achillion Pharmaceuticals | 3.3 | $3.3M | 480k | 6.91 | |
| BioCryst Pharmaceuticals (BCRX) | 2.9 | $2.9M | 259k | 11.40 | |
| Aerie Pharmaceuticals | 2.9 | $2.9M | 166k | 17.74 | |
| Biotelemetry | 2.9 | $2.9M | 236k | 12.24 | |
| Insulet Corporation (PODD) | 2.7 | $2.7M | 106k | 25.91 | |
| Rigel Pharmaceuticals | 2.7 | $2.7M | 1.1M | 2.47 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 2.7 | $2.7M | 4.0M | 0.67 | |
| Discovery Laboratories | 2.2 | $2.3M | 7.5M | 0.30 | |
| Insulet Corp note 2.000% 6/1 | 2.2 | $2.2M | 2.4M | 0.93 | |
| Applied Genetic Technol Corp C | 2.0 | $2.1M | 157k | 13.14 | |
| Otonomy | 2.0 | $2.0M | 112k | 17.81 | |
| Masimo Corporation (MASI) | 1.8 | $1.8M | 46k | 38.56 | |
| Derma Sciences | 1.7 | $1.7M | 357k | 4.71 | |
| XenoPort | 1.6 | $1.6M | 471k | 3.47 | |
| Synergy Pharmaceuticals | 1.6 | $1.6M | 297k | 5.30 | |
| Essa Pharma | 1.4 | $1.4M | 229k | 6.23 | |
| Protalix BioTherapeutics | 1.4 | $1.4M | 1.2M | 1.18 | |
| Cytrx | 1.4 | $1.4M | 583k | 2.37 | |
| Cara Therapeutics (CARA) | 1.3 | $1.3M | 94k | 14.29 | |
| Neos Therapeutics | 1.3 | $1.3M | 63k | 21.01 | |
| Stereotaxis (STXS) | 1.3 | $1.3M | 1.4M | 0.93 | |
| Celyad Sa | 1.2 | $1.3M | 30k | 41.87 | |
| Avalanche Biotechnologies In | 1.1 | $1.2M | 141k | 8.24 | |
| Scynexis | 1.1 | $1.1M | 157k | 7.28 | |
| Novadaq Technologies | 1.1 | $1.1M | 102k | 10.43 | |
| Dicerna Pharmaceuticals | 1.0 | $1.0M | 124k | 8.21 | |
| Nuvasive Inc. conv | 0.9 | $958k | 760k | 1.26 | |
| Spectranetics Corporation | 0.9 | $941k | 80k | 11.79 | |
| Ascendis Pharma A S (ASND) | 0.9 | $942k | 53k | 17.69 | |
| Zogenix | 0.9 | $930k | 69k | 13.50 | |
| Johnson & Johnson (JNJ) | 0.9 | $877k | 9.4k | 93.30 | |
| Vitae Pharmaceuticals | 0.8 | $780k | 71k | 11.00 | |
| Intec Pharma | 0.8 | $756k | 135k | 5.60 | |
| Abeona Therapeutics | 0.7 | $736k | 182k | 4.05 | |
| Arena Pharmaceuticals | 0.7 | $729k | 382k | 1.91 | |
| Uniqure Nv (QURE) | 0.7 | $716k | 35k | 20.46 | |
| Cynapsus Therapeutics | 0.7 | $707k | 45k | 15.77 | |
| Akari Therapeutics | 0.6 | $633k | 26k | 23.99 | |
| Syneron Medical Ltd ord | 0.6 | $615k | 86k | 7.16 | |
| Alder Biopharmaceuticals | 0.6 | $590k | 18k | 32.78 | |
| Regulus Therapeutics | 0.6 | $589k | 90k | 6.54 | |
| Gilead Sciences (GILD) | 0.6 | $560k | 5.7k | 98.25 | |
| Celgene Corporation | 0.6 | $562k | 5.2k | 108.08 | |
| Caredx (CDNA) | 0.6 | $567k | 136k | 4.17 | |
| Exactech | 0.6 | $551k | 32k | 17.42 | |
| Ironwood Pharma note 2.25% 15-jun-2022 144a sr unsecured conv | 0.5 | $540k | 600k | 0.90 | |
| Lipocine | 0.5 | $532k | 45k | 11.82 | |
| Cynapsus Therapeutics | 0.5 | $536k | 34k | 15.77 | |
| Targacept Inc Conv Dtd convertible | 0.5 | $531k | 531k | 1.00 | |
| Dermira | 0.5 | $525k | 23k | 23.33 | |
| Amgen (AMGN) | 0.5 | $512k | 3.7k | 138.38 | |
| Bluebird Bio (BLUE) | 0.5 | $513k | 6.0k | 85.50 | |
| Macrogenics (MGNX) | 0.5 | $514k | 24k | 21.42 | |
| Vtv Therapeutics Inc- Cl A | 0.5 | $489k | 75k | 6.52 | |
| Lumenis Ltd shs cl b | 0.4 | $430k | 31k | 13.84 | |
| Cogentix Medical | 0.4 | $436k | 352k | 1.24 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 0.4 | $436k | 45k | 9.67 | |
| Intercept Pharmaceuticals In | 0.4 | $403k | 2.4k | 165.84 | |
| Cardica | 0.4 | $379k | 1.4M | 0.27 | |
| Catalyst Biosciences | 0.3 | $330k | 71k | 4.65 | |
| Tandem Diabetes Care | 0.3 | $322k | 37k | 8.81 | |
| Check Cap | 0.3 | $307k | 110k | 2.79 | |
| Tenax Therapeutics | 0.2 | $245k | 82k | 3.01 | |
| Genvec | 0.2 | $221k | 96k | 2.31 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $207k | 25k | 8.28 | |
| Venaxis | 0.2 | $202k | 650k | 0.31 | |
| Loxo Oncology | 0.2 | $205k | 12k | 17.45 | |
| Nivalis Therapeutics | 0.2 | $195k | 15k | 13.00 | |
| Marinus Pharmaceuticals | 0.2 | $186k | 22k | 8.33 | |
| Pronai Therapeutics | 0.2 | $174k | 8.5k | 20.47 | |
| Actinium Pharmaceuticals | 0.2 | $159k | 90k | 1.77 | |
| Trevena | 0.1 | $153k | 15k | 10.34 | |
| EnteroMedics | 0.1 | $130k | 500k | 0.26 | |
| CAS Medical Systems | 0.1 | $108k | 87k | 1.24 | |
| Oncothyreon | 0.1 | $99k | 36k | 2.74 | |
| Chembio Diagnostics | 0.1 | $88k | 22k | 4.05 | |
| Antares Pharma | 0.1 | $77k | 45k | 1.71 | |
| Cel-sci | 0.1 | $84k | 140k | 0.60 | |
| Aptose Biosciences | 0.1 | $83k | 19k | 4.31 | |
| Corbus Pharmaceuticals Hldgs | 0.1 | $79k | 50k | 1.58 | |
| Galapagos Nv- (GLPG) | 0.1 | $70k | 1.7k | 40.96 | |
| Advaxis | 0.1 | $51k | 5.0k | 10.20 | |
| Galmed Pharmaceuticals | 0.0 | $44k | 5.9k | 7.49 | |
| Check Cap Ltd w exp 02/28/202 | 0.0 | $28k | 55k | 0.51 |
